ABSTRACT OBJECTIVES This study investigated the long-term outcomes and predictors of target vessel failure (a composite of cardiac death, myocardial infarction, stent thrombosis, or target vessel revascularization) in patients with bifurcation lesion treated by percutaneous coronary intervention (PCI) utilizing the 2-stent strategy with a drug-eluting stent (DES).
Song et al. Figure S1 ). QCA measurements were performed at baseline and after stent implantation on both MVs and SB with a Centricity CA 1000 automated edgedetection system (GE, Waukesha, Wisconsin) using standard qualitative and quantitative analyses and definitions (6) . Reference vessel diameters, minimal lumen diameter, and bifurcation angle were measured. The bifurcation angle was defined as the angle between the distal MV and the SB at its origin using the angiographic projection with the widest separation of the 2 branches. priate. Time-to-event curves were generated using the Kaplan-Meier method and were compared using the log-rank test. Multivariate Cox proportional-hazards had a protective effect on the occurrence of TVF in the 2-stent strategy bifurcation PCI ( Table 5) . Detailed features of patients with stent thrombosis in the second-generation DES stratum are listed in Online Table S7 . High SYNTAX score (>32) remained an independent predictor for 3-year TVF even in the second-generation DES stratum (Online Table S8 ).
DISCUSSION
There are 2 main findings from our study. The Nordic Stent Technique Study found 18.6% major adverse cardiac events (the composite of cardiac death, myocardial infarction, stent thrombosis, and target vessel revascularization) in the overall population during a 3-year follow-up (12), which suggests that our results are comparable considering that our population included many more patients with left main bifurcation lesions (39.1% in the present study vs. 9.7% in the Nordic Stent Technique Study). In addition, previous data on the safety of the 2-stent strategy are limited, and concern has been raised about long-term safety outcomes, particularly stent thrombosis (13) . Among the 951 patients, we identified 16 cases (1.7%) of stent thrombosis over 36.1 months of follow-up. This incidence of stent thrombosis is in line with the previous studies in which the rate of stent thrombosis was 2% to 4% on a long-term basis for bifurcation lesions treated with a 2-stent technique (12, 14) . The most interesting point of the present study is that every patient with early stent thrombosis were not taking dual antiplatelet agents, such as aspirin and thienopyridine, and all but 1 patient with very late stent thrombosis was taking dual antiplatelet agents at the time of presentation.
Whether the duration of dual antiplatelet therapy should be longer than the currently recommended 6 to 12 months will need further analysis in the 
DIABETES MELLITUS IN BIFURCATION LESIONS.
A recent study (23) showed that diabetes mellitus is a strong predictor of repeat revascularization with DES. CVA ¼ cerebrovascular accident; TLR ¼ target lesion revascularization; other abbreviations as in Table 2 . 365  730  1095  0  365  730  1095  0  365  730  1095  0  365  730  1095  0  365  730  1095   951  801  695  455  951  888  790  526  951  871  778  516  951  883  785  523  951  806 Song et al.
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